Vector independent transmission of the vector-borne bluetongue virus

被引:31
作者
van der Sluijs, Mirjam Tineke Willemijn [1 ]
de Smit, Abraham J. [2 ]
Moormann, Rob J. M. [3 ,4 ]
机构
[1] MSD Anim Hlth, Res & Dev, Wim Korverstr 35,POB 31, NL-5830 AA Boxmeer, Netherlands
[2] Merial, Res & Dev, Lyon, France
[3] Cent Vet Inst, Lelystad, Netherlands
[4] Univ Utrecht, Dept Infect Dis & Immunol, Div Virol, Yalelaan, Netherlands
关键词
Bluetongue; cattle; sheep; transmission; vaccination; INDUCED CONGENITAL ENCEPHALOPATHIES; EXPERIMENTALLY INFECTED SHEEP; SEROTYPE; 8; TRANSPLACENTAL TRANSMISSION; INACTIVATED VACCINE; CULICOIDES-VARIIPENNIS; GENOME SEGMENT; PREGNANT EWES; CATTLE; CALVES;
D O I
10.3109/1040841X.2013.879850
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bluetongue is an economically important disease of ruminants. The causative agent, Bluetongue virus (BTV), is mainly transmitted by insect vectors. This review focuses on vector-free BTV transmission, and its epizootic and economic consequences. Vector-free transmission can either be vertical, from dam to fetus, or horizontal via direct contract. For several BTV-serotypes, vertical (transplacental) transmission has been described, resulting in severe congenital malformations. Transplacental transmission had been mainly associated with live vaccine strains. Yet, the European BTV-8 strain demonstrated a high incidence of transplacental transmission in natural circumstances. The relevance of transplacental transmission for the epizootiology is considered limited, especially in enzootic areas. However, transplacental transmission can have a substantial economic impact due to the loss of progeny. Inactivated vaccines have demonstrated to prevent transplacental transmission. Vector-free horizontal transmission has also been demonstrated. Since direct horizontal transmission requires close contact of animals, it is considered only relevant for within-farm spreading of BTV. The genetic determinants which enable vector-free transmission are present in virus strains circulating in the field. More research into the genetic changes which enable vector-free transmission is essential to better evaluate the risks associated with outbreaks of new BTV serotypes and to design more appropriate control measures.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 91 条
[1]   BLUETONGUE DISEASE IN DOGS ASSOCIATED WITH CONTAMINATED VACCINE [J].
AKITA, GY ;
IANCONESCU, M ;
MACLACHLAN, NJ ;
OSBURN, BI ;
GREENE, RT .
VETERINARY RECORD, 1994, 134 (11) :283-284
[2]  
ANDERSON CK, 1969, AM J VET RES, V30, P987
[3]  
[Anonymous], P 6 EP ANN M
[4]   Transplacental and oral transmission of wild-type bluetongue virus serotype 8 in cattle after experimental infection [J].
Backx, Anoek ;
Heutink, Rene ;
van Rooij, Eugene ;
van Rijn, Piet .
VETERINARY MICROBIOLOGY, 2009, 138 (3-4) :235-243
[5]  
BARNARD B J H, 1976, Onderstepoort Journal of Veterinary Research, V43, P155
[6]   Bluetongue virus serotype 26: Infection kinetics and pathogenesis in Dorset Poll sheep [J].
Batten, C. A. ;
Henstock, M. R. ;
Bin-Tarif, A. ;
Steedman, H. M. ;
Waddington, S. ;
Edwards, L. ;
Oura, C. A. L. .
VETERINARY MICROBIOLOGY, 2012, 157 (1-2) :119-124
[7]   A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment [J].
Batten, Carrie A. ;
Maan, Sushila ;
Shaw, Andrew E. ;
Maan, Narender S. ;
Mertens, Peter P. C. .
VIRUS RESEARCH, 2008, 137 (01) :56-63
[8]   Duration of viraemia infectious to Culicoides sonorensis in bluetongue virus-infected cattle and sheep [J].
Bonneau, KR ;
DeMaula, CD ;
Mullens, BA ;
MacLachlan, NJ .
VETERINARY MICROBIOLOGY, 2002, 88 (02) :115-125
[9]   Occurrence of genetic drift and founder effect during quasispecies evolution of the VP2 and NS3/NS3A genes of bluetongue virus upon passage between sheep, cattle, and Culicoides sonorensis [J].
Bonneau, KR ;
Mullens, BA ;
MacLachlan, NJ .
JOURNAL OF VIROLOGY, 2001, 75 (17) :8298-8305
[10]   Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats [J].
Breard, E. ;
Belbis, G. ;
Hamers, C. ;
Moulin, V. ;
Lilin, T. ;
Moreau, F. ;
Millemann, Y. ;
Montange, C. ;
Sailleau, C. ;
Durand, B. ;
Desprat, A. ;
Viarouge, C. ;
Hoffmann, B. ;
de Smit, H. ;
Goutebroze, S. ;
Hudelet, P. ;
Zientara, S. .
VACCINE, 2011, 29 (13) :2495-2502